Industry Resource Center


Industry Partnership
The International Parkinson and Movement Disorder Society partners with international industry to bring the latest science, medical, and research developments to our members as well as other movement disorders professionals around the world.

Sponsored by:



Resources for MDS Members who practice within the United States

ANNOUNCEMENT:  In November 2015, the FDA approved a modified indication statement for the use of DBS for Parkinson’s disease.  Following is the new indication:

Bilateral stimulation of the internal globus pallidus (GPi) or the subthalamic nucleus (STN) using Medtronic DBS Therapy for Parkinson's Disease is indicated for adjunctive therapy in reducing some of the symptoms in individuals with levodopa-responsive Parkinson's disease of at least 4 years’ duration that are not adequately controlled with medication including motor complications of recent onset (from 4 months to 3 years) or motor complications of longer-standing duration.

This therapy is not for everyone. DBS Therapy requires brain surgery which could have serious or even fatal complications. Other complications can occur and may require additional surgery.  Medtronic DBS Therapy may cause worsening of some symptoms.   For additional safety information, please refer to Indications, Safety and Warnings.

Medtronic Patient Support Link

If your patients are considering DBS Therapy, they need Support Link. It connects them with those who already benefit from DBS therapy, nurses who specialize in it, experts in the device and many other resources. Support Link makes it easy for your patients to get answers, whether they prefer to talk to someone on the phone, watch videos, join a webinar, or read materials at their leisure. We also reach out by phone to learn more about them and their journey. Support Link helps your patients make a confident decision before this treatment opportunity ends.

Your patients can opt-in to Support Link via the following links or by calling our Support Link team at +1 877-438-3574.

Support Link Opt-in Links:

Physician Finder for Patients

On the Medtronic patient website, patients may look for a physician in their area with whom to discuss DBS Therapy by using the “find a specialist” feature. If interested in being added to the Medtronic DBS Therapy physician finder list, you must meet the following criteria:  

  • Either 4 implants in a rolling year, or manage 4 patients in a rolling year.

To be listed, please send an email to and include your name, contact information and email address.

Marketing Resources to Promote Your Center

Within the Medtronic DBS website,, you will find the following helpful resources to use in promoting your center:

Resources for MDS Members who practice outside of the United States

Click to download.


Learn more about criteria and tools to support appropriate referrals for Deep Brain Stimulation. Click here to download a PDF with more information.




MRI a Standard of Care





















MRI has become a standard of care:  In 2013, there were 33.8 million scans in the U.S. Approximately 7 out of 10 DBS-eligible patients with movement disorders may need an MRI within 10 years of receiving their device. 62% of MRI examinations of DBS-eligible patients with movement disorders are in regions of the body other than the head. Now, it is safe for eligible Medtronic DBS Therapy patients to have a MRI scan anywhere on the body under specific conditions*. Medtronic offers the first and only full-body MR Conditional DBS sytems.*

To find more information about the guidelines for performing an MRI with Medtronic DBS devices, please visit


1 Falowski S, Safriel Y, Ryan M, Hargens L. The need for magnetic resonance (MR) imaging in the United States (US) deep brain stimulation (DBS) population. Presented at: 18th Annual North American Neuromodulation Society Conference; December 11-14, 2014; Las Vegas, NV. Erratum: FDA first approved MR Condit.

*Medtronic DBS systems are MR Conditional and safe in the MR environment as long as certain conditions are met.  If the conditions are not met, a significant risk is tissue lesions from component heating, especially at the lead electrodes, resulting in serious and permanent injury including coma, paralysis, or death.  Refer to product labeling for a complete list of conditions.


Disclaimer: The International Parkinson and Movement Disorder Society is providing this content in partnership with industry partners. MDS does not sanction or endorse any service or product mentioned in this offer.